Answers are grounded in this paper and cite their sources.
This EQA study demonstrates that there is room for many laboratories to improve sensitivity in the detection of anti-dengue virus IgM antibodies, against the benchmark set by commercial antibody capture ELISA tests. The EQA shows also that cross-reactivity is a continuing issue, and IgG detection protocols must be optimized to increase their specificity.
No takes yet. Share an insight, caveat, or question.
Domingo et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: